Skip to main content
. 2013 Mar 22;304(10):H1294–H1301. doi: 10.1152/ajpheart.00637.2012

Fig. 2.

Fig. 2.

Reactive hyperemia is attenuated in the presence of glibenclamide. A: group data present baseline flow and the hyperemic response following a 15-s total occlusion of coronary flow. Responses were significantly reduced in hearts with KATP channel blockade by glibenclamide (10 μM, n = 5). B: repayment of flow debt was reduced by 54.4% in WT mice treated with glibenclamide (*P < 0.05 vs. WT by unpaired t-test) (n = 5).